October 11th 2024
There is still no formal or professional recognition of complex PTSD as a very different disorder than what DSM-5-TR describes for PTSD.
The Role of Psychedelics in Psychiatry: A Conversation With Rachel Dalthorp, MD, MHSA
June 4th 2024The FDA Meeting of the Psychopharmacologic Drugs Advisory Committee evaluating the New Drug Application for MDMA is happening now. How do clinicians feel about this potential treatment for PTSD?
Read More